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Abstract
Proteins contributing to a complex disease are often members of the same functional pathways. Elucidation of such
pathways may provide increased knowledge about functional mechanisms underlying disease. By combining genetic
interactions in Type 1 Diabetes (T1D) with protein interaction data we have previously identified sets of genes, likely to
represent distinct cellular pathways involved in T1D risk. Here we evaluate the candidate genes involved in these putative
interaction networks not only at the single gene level, but also in the context of the networks of which they form an integral
part. mRNA expression levels for each gene were evaluated and profiling was performed by measuring and comparing
constitutive expression in human islets versus cytokine-stimulated expression levels, and for lymphocytes by comparing
expression levels among controls and T1D individuals. We identified differential regulation of several genes. In one of the
networks four out of nine genes showed significant down regulation in human pancreatic islets after cytokine exposure
supporting our prediction that the interaction network as a whole is a risk factor. In addition, we measured the enrichment
of T1D associated SNPs in each of the four interaction networks to evaluate evidence of significant association at network
level. This method provided additional support, in an independent data set, that two of the interaction networks could be
involved in T1D and highlights the following processes as risk factors: oxidative stress, regulation of transcription and
apoptosis. To understand biological systems, integration of genetic and functional information is necessary, and the current
study has used this approach to improve understanding of T1D and the underlying biological mechanisms.
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Introduction
Currently, genome-wide association studies in complex diseases
are producing an unprecedented amount of genetic data. Complex
traits like Type 1 Diabetes (T1D) are influenced by multiple genes
interacting with each other to confer susceptibility and/or
protection. However, identifying the individual components can
be difficult because each only contributes weakly to the pathology.
Alternatively, identification of entire cellular systems involved in a
particular disease could be attempted. Such a strategy should be
feasible in many different complex diseases since most genes exert
their function as members of molecular machines where groups of
proteins contributing to disease can be expected to be members of
the same functional pathways [1,2,3,4,5,6]. Analysis of an entire
disease-related system might provide insight to the molecular
etiology of the disease that would not emerge from isolated
functional studies of single genes.
We have previously in a large T1D linkage data set
demonstrated statistical evidence for gene-gene interactions [7].
The data set comprised data from 1,321 affected sib pairs
genotyped for 298 microsatellite markers [7,8]. By an integrative
approach combining genetic data and high-confidence (human)
protein interaction networks, we identified four protein interaction
networks significantly enriched in proteins from the predicted
genetic interactions. This supported interaction in biological
pathways. For each of these networks the identified protein or
proteins were viewed in a biological context [7].
However, further functional and genetic evaluation is necessary
to confirm the involvement of these interactions in T1D, elucidate
the biological mechanisms of these networks and to identify the
strongest risk factors amongst the network members. If several
members of the same network can be shown to be likely risk
factors in independent data this would support that the interaction
networks as such are risk factors and serve as a validation of the
genetic interactions previously identified. In the current study we
use independent approaches for evaluating interaction networks
and identifying the strongest risk factors amongst network
members. We have used available T1D genome-wide association
PLoS ONE | www.plosone.org 1 July 2009 | Volume 4 | Issue 7 | e6250scan data for evaluation of whether entire interaction networks
could be significantly associated with T1D. Furthermore, we
performed expression profiling of identified genes. The hypothesis
behind this is that expression levels may act as intermediate
phenotypes between DNA sequence variation and more complex
disease phenotypes and that evaluation of the expression of
candidate genes in relevant tissue and/or disease models may
provide a means for identifying those with a functional implication
in T1D pathogenesis.
Results and Discussion
We have evaluated expression levels of candidate genes
previously identified through genetic and protein interaction
analyses [7]. The selected candidate genes originate from linkage
regions predicted to genetically interact, and are functionally
supported by evidence for physical interaction at the level of
protein complexes. Four functional interaction networks (A–D)
containing 30 proteins presumed to be responsible for the genetic
interactions were previously obtained [7], and these four putative
pathways and their 30 members were further evaluated in the
present study.
In a model of T1D, expression levels were evaluated in human
islet preparations, representing the target organ, as well as in
human lymphocytes representing the effector cells in T1D.
Expression profiling in human islets was performed by comparing
the constitutive expression versus cytokine-stimulated expression
levels. Gene expression levels in lymphocytes were compared
among controls and T1D individuals.
Additional support for individual genes and genetic interactions
in the networks comes from evidence for genetic association. The
WellcomeTrustCase ControlConsortium(WTCCC) has made the
results of their large genome-wide association study of T1D and
otherdiseasespubliclyavailable (www.wtccc.org)[9].Inthis data set
we searched for T1D associated SNPs in the 30 candidate genes
located in the four interaction networks. To test for combined
evidence for T1D association of the protein networks we measured
the over-representation (enrichment) of significant SNPs associated
with T1D in the four interaction networks, compared to randomly
generated networks with similar properties. For each network we
testedthe enrichment ofSNPs inthebest 0.1percentile, 1 percentile
and 5 percentile of the WTCCC data for T1D. A nominal P-value
and an adjusted P-value was determined for enrichment at each of
those thresholds by comparing to 1,000 randomly generated
networks with an equal number of proteins and proteins encoded
by genes of similar size to the actual test genes.
Interaction network A, table 1 and figure 1, represents genetic
interactions between the HLA region on chromosome 6 and a
region on chromosome 13, a region on chromosome 4, as well as
regions on chromosome 16 and 2. Based on validated protein-
protein interactions the proteins/genes responsible for these
interactions in network A are the four HLA region genes, BAT1
(Spliceosome RNA helicase, HLA-B associated transcript-I),
ITPR3 (Inositol 1,4,5-triphosphate receptor type 3), RPS18 (40S
ribosomal protein S18) and TUBB (Tubulin beta-2 chain)
interacting with the LMO7 (LIM domain only protein 7) gene
on chromosome 13, the WDR1 (WD repeat domain I) gene on
chromosome 4, the RPS15A (40S ribosomal protein S15a) on
chromosome 16 and the HNRPLL (Heterogeneous nuclear
ribonucleoprotein L-like, stromal RNA-regulating factor) on
chromosome 2, as well as two genes directly interacting from
other chromosomal regions, DNAJC14 (Nuclear protein Hcc-1,
proliferation associated cytokine-inducible protein CIP29) and
ELF5 (ETS-related transcription factor Elf-5). Network A is
significantly enriched, after correction for multiple testing, for
SNPs in the 0.1 percentile and the 1 percentile, and borderline
significant for SNPs in the best 5 percentile of the WTCCC study,
table 2, indicating that the interaction network as a whole is a risk
factor in T1D and further supporting the genetic interactions
observed in previous work. For genes in network A no significant
differences in expression levels between lymphocytes from eight
newly diagnosed T1D patients and nine control individuals was
identified. For the nine human islet preparations we found that
four of the genes demonstrated significant down-regulation upon
cytokine-stimulation. These were BAT1, RPS18 and TUBB from
the HLA-region and the WDR1 gene, on the short arm of
chromosome 4, a gene involved in actin binding, table 1 and
figure 1. This gives further support to these four genes as
functionally relevant in this model of T1D (human islets stimulated
with cytokines). Neither the RPS18 nor the TUBB gene has known
functional roles in relation to T1D. The BAT1 gene has been
designated HLA-B associated transcript and BAT1 is a negative
regulator of inflammation [10], probably affecting production of
TNFa, IL-1b and IL-6. WD-repeats are involved in protein-
protein interactions and have been shown to be involved in
regulation of transcription, mRNA modification and transmem-
brane signaling, and mutations in the Wdr1 gene has in a mouse
model been shown to be related to auto-inflammation [11,12].
Such effects may be relevant in T1D.
Interaction network B, table 1 and figure 2, consists of two HLA
region genes, RDBP (RD RNA-binding protein, MHC complex
gene RD) and GTF2H4 (General transcription factor II H)
interacting with two genes from a region on chromosome 16,
RRN3 (RNA polymerase I-specific transcription initiation factor)
and ERCC4 (DNA excision repair protein, DNA repair endonucle-
ase) and the TAF1A (TATA box binding protein (TBP)-associated
factor, RNA polymerase I) gene on chromosome 1. The ERCC4
gene furthermore directly interacts with the TYW3 (tRNA–yW
synthesizing protein 3 homolog) and the GUF1 (GTP-binding
protein GUF1 homolog, GTPase of unknown function) genes from
other regions. Comparing the constitutive expression level of these
genes in human pancreatic islets with the level after cytokine-
exposure of the islets did not identify significant differences. When
comparingexpression levelsbetween newly diagnosedT1Dpatients
and controls, we demonstrated a significantly higher expression
level of the TAF1A gene in the T1D patients, table 1 and figure 2.
The TAF1A gene on chromosome 1 encodes a transcription factor
involved in RNA synthesis. It has not been implicated in T1D
before and the effect of different expression levels in relation to
disease state in human lymphocytes is not clear, neither is the
putative functional effect on the other network B genes by this
difference. No enrichment of T1D associated SNPs in this
interaction network could be demonstrated, providing no further
genetic support to this network.
Interaction network C contains only three genes and originates
from an identified gene-gene interaction between the HLA-region
and a region on chromosome 11. Genes predicted to be
responsible for this interaction is the MOG (Myelin-oligodendro-
cyte glycoprotein precursor) gene on chromosome 6 and the
APLP2 (Amyloid-like protein 2 precursor (APPH)) and NTRI
(Neurotrimin precursor (hNT)) genes on chromosome 11, table 1.
No significant differences in either of the tissues/model systems
were demonstrated for these genes, not providing any functional
support from expression studies for the network C genes, also no
enrichment of T1D associated SNPs was observed in this network.
Interaction network D, table 1 and figure 3, originates from
predicted genetic interactions among a region on chromosome 17,
and markers on chromosomes 5, 1 and 2. Candidate genes
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(Probable ATP-dependent RNA helicase DDX52, DEAD box
protein 52) and RPL23A (60S ribosomal protein L23a) on
chromosome 17, NPM1 (Nucleophosmin, nucleolar phosphopro-
tein B23) and RPL26L1 (60S ribosomal protein L26-like I) on
chromosome 5, PRDX1 (Natural killer cell-enhancing factor A,
Peroxiredoxin-I) on chromosome 1 and RPS7 (40S ribosomal
protein S7) on chromosome 2. The PRDX1 gene additionally
interacts with the SESN2 (Sestrin 2, hypoxia induced gene 95) and
SESN1 (Sestrin 1, p53-regulated protein PA26) genes, of which the
latter further interacts with the FLOT1 (Flotillin I, integral
membrane component of caveolae) gene from the HLA region.
Interaction network D is significantly enriched for SNPs in the best
0.1 percentile, table 2, indicating that genetic variations in this
network could also contribute to T1D susceptibility. No differences
in the lymphocyte expression studies were demonstrated. Com-
paring human islets expression profiles, we demonstrated that
NPM1, a gene involved in ribosomal protein assembly and
transport was significantly down-regulated upon stimulation of
islets with a mixture of cytokines and the PRDX1 gene, encoding a
natural killer cell enhancing factor, to be significantly up-regulated
after such stimulation, when compared to constitutive expression,
table 1 and figure 3. Natural killer cell enhancing factors have
been described as important for different cells in their defense
against oxidants/oxidative stress [13,14]. An up-regulation of the
PRDX1 encoded protein could be part of a defense mechanism in
Table 1. Expressional profiling of thirty candidate genes divided into four interaction networks (A–D) demonstrating genetic and
protein interactions.
Gene symbol Chr.position Gene name P-value
Network A.
BAT1 6p21.33 Spliceosome RNA helicase BAT1 HLA-B associated transcript-1 P=0.008
ITPR3 6p21.31 Inositol 1,4,5-trisphosphate receptor type 3 NS
RPS18 6p21.32 40S ribosomal protein S18 Ke-3 P=0.0004
TUBB 6p21.33 Tubulin beta-2 chain P=0.03
HNRPLL 2p22.1 Heterogeneous nuclear ribonucleoprotein L-like Stromal RNA-regulating factor NS
LMO7 13q22.2 LIM domain only protein 7 LOMP F-box only protein 20 NS
WDR1 4p16.1 WD repeat domain 1 WDR1, transcript variant 1 P=0.03
RPS15A 16p12.3 40S ribosomal protein S15a NS
DNAJC14 12q13.2 Nuclear protein Hcc-1 Proliferation associated cytokine-inducible protein CIP29 NS
ELF5 11p13 ETS-related transcription factor Elf-5 E74-like factor 5 NS
Network B.
RDBP 6p21.3 RD RNA-binding protein, major histocompatibility complex gene RD NS
GTF2H4 6p21.3 Basic transcription factor 2 89 kDa subunit, DNA excision repair protein ERCC-3 NS
RRN3 16p13.11 RNA polymerase I-specific transcription initiation factor NS
ERCC4 16p13.12 DNA excision repair protein, DNA repair endonuclease NS
TAF1A 1q41 TATA box binding protein TBP-associated factor, RNA polymerase I P=0.04
TYW3 1p31.1 tRNA-yW synthesizing protein 3 homolog NS
GUF1 4p13 GTP-binding protein GUF1 homolog, GTPase of unknown function NS
Network C.
MOG 6p22.1 Myelin-oligodendrocyte glycoprotein precursor NS
APLP2 11q24.3 Amyloid-like protein 2 precursor APPH NS
NTRI 11q25 Neurotrimin precursor hNT NS
Network D.
DDX52 17q12 Probable ATP-dependent RNA helicase DDX52 DEAD box protein 52 NS
RPL23A 17q11.2 60S ribosomal protein L23a NS
NPM1 5q35.1 Nucleophosmin NPM Nucleolar phosphoprotein B23 P=0.004
RPL26L1 5q35.1 60S ribosomal protein L26-like 1 NS
PRDX1 1p34.1 Natural killer cell-enhancing factor A, Peroxiredoxin-1 P=0.003
RPS7 2p25.3 40S ribosomal protein S7 NS
NGB 14q24.3 Neuroglobin NS
FLOT1 6p21.33 Flotillin 1, integral membrane component of caveolae NS
SESN1 6q21 Sestrin-1 p53-regulated protein PA26 NS
SESN2 1p35.3 Sestrin-2, hypoxia induced gene 95 Hi95 NS
Only p-values below 0.05 are considered statistically significant and are included in the table. Non-significant is indicated by NS. TAF1A in module B demonstrated
differential expression in lymphocytes (T1D vs. controls) whereas the other significant p-values correspond to comparisons of un-stimulated vs. cytokine-stimulated
human pancreatic islets.
doi:10.1371/journal.pone.0006250.t001
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shown to be important in certain cancer forms, and it has been
described that inhibition of the expression of this gene may cause
other proteins, e.g. STAT5A to act as a tumor suppressor [15].
This network, build on genetic interactions between chromosome
17 and chromosomes 5, 1 and 2, may be interesting in individuals
with a low HLA risk, even though a second order interaction with
a gene from the HLA region was found in the protein interactions.
The network could point at underlying mechanisms and putatively
important combinations of genes responsible for T1D in such
individuals. A stronger effect of non-HLA genes could be expected
in individuals carrying a lower HLA risk, as indicated by a recent
T1D genome-wide association scan and meta-analysis [16].
In three out of four interaction networks our attempts to
functionally characterize the candidate genes by expressional
profiling have identified novel genes for further analysis. The third
interaction network, network C, did not reveal any differentially
expressed genes. Genetic support by evaluation of whether
networks were enriched in T1D associated SNPs was obtained
for network A and to a lesser degree for network D, highlighting
these two interaction networks as the most important.
A recently published study evaluated changes at the proteome
level after cytokine stimulation of INS-1E cells (a rat tumor beta-
cell line serving as an in vitro model for T1D) [17]. Among the
proteins that changed expression levels after 4 hours of stimulation
with IL-1b and IFN-c were the rat gene products of the WDR1
and NPM1 genes and after 24 hours the PRDX1 protein was highly
up-regulated. In that study a large protein interaction network
containing many of the differentially expressed proteins including
WDR1, NPM1 and PRDX1 was identified [17]. Despite use of
different species and model systems and unknown dynamic
differences in the transcriptome and proteome we find it of
interest that these three genes were pin-pointed as functionally
relevant in the current study as well as in the study by D’Hertog
Figure 1. Overview of predicted interactions in network A. Protein-protein interactions in this network originates from predicted genetic
interactions between the HLA-region on chromosome 6 (BAT1, ITPR3, RPS18 and TUBB) and chromosomal regions on chromosome 2 (around D2S177,
HNRPL), chromosome 13 (D13S170, LMO7), chromosome 4 (D4S403, WDR1) and chromosome 16 (D16S287, RPS15A), respectively. The ELF5 gene is
positioned on chromosome 11. Red arrows and corresponding plots refer to four genes that were demonstrated significantly down-regulated in
human pancreatic islets upon cytokine-stimulation. In the plots nodes to the left represent expression levels for all nine donors in un-stimulated
condition, whereas nodes to the right represent cytokine-stimulated expression levels.
doi:10.1371/journal.pone.0006250.g001
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two studies has a P-value of,0.05, as calculated using hypergeo-
metric statistics.
To understand biological systems integration of genetic and
functional information is necessary. This includes studies of gene-
gene and protein-protein interactions and transcriptional or
proteome profiling. In a previous study we identified genetic
interactions observed in T1D and explained their functionality by
using an approach for integrating protein-protein interactions
generating protein interaction networks. In this work we validated
the discovered networks and analyzed their functionality by
expressional profiling in relevant target tissue and by using SNP
association data. Protein interaction data generally are noisy and
databases probably contain many false positives. The system used
in the current study is, however, rigorously quality controlled to
only include interactions that have been replicated in independent
screens [18].
GO (gene ontology) terms (www.geneontology.org) for molecular
function and biological processes of interaction networks A and D
and the differentially expressed genes in particular support that
oxidative stress and regulation of transcription and apoptosis are of
relevance for beta-cell destruction in T1D pathogenesis, and points
directly at these pathways as the most important. Despite the overall
impression from recent genome-wide association studies [9,19,20]
that genes of importance in T1D are mainly immune system genes
Table 2. The enrichment of the four interaction networks for
significant SNPs associated with T1D in the WTCCC study is
measured.
0.1 Percentile 1 Percentile 5 Percentile
Network A
P-value ,0.001 ,0.001 0.005
Adjusted P-value ,0.012 ,0.012 0.06
Network B
P-value 0.024 0.193 0.648
Adjusted P-value 0.28 1.0 1.0
Network C
P-value 1.0 0.591 0.301
Adjusted P-value 1.0 1.0 1.0
Network D
P-value 0.003 0.121 0.172
Adjusted P-value 0.036 1.0 1.0
P-values refer to a comparison with randomly generated modules with similar
properties. P-values and adjusted p-values corrected for multiple testing are
provided for all three percentiles of SNPs in each network.
doi:10.1371/journal.pone.0006250.t002
Figure 2. Protein-protein interactions in network B, originating from predicted genetic interactions between the HLA region on
chromosome 6 (RDBP and GTF2H4) and chromosomal regions on chromosome 16 (D16S287, RRN3 and ERCC4)) and chromosome 1
(D1S229, TAF1A). The TAF1A gene demonstrated significantly higher expression in lymphocytes from T1D patients compared to lymphocytes from
control individuals. The TYW3 and GUF1 are positioned on chromosome 1p31.1 and 4p13, respectively.
doi:10.1371/journal.pone.0006250.g002
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genes involved in the genetic disposition to e.g. cytokine induced
beta-cell death by apoptosis can be identified.
Only few studies have addressed genetic interaction in T1D and
focused on interactions between classical disease loci [21,22,23],
and in the case of high risk HLA class II genotypes and PTPN22 a
less than multiplicative association has been demonstrated in T1D
and rheumatoid arthritis [16,24,25]. The general impression is
that interactions may exist, even though they have been difficult to
identify. Attempts to identify gene-gene interactions in T1D in
previous studies, e.g. in the recent T1D genome wide association
studies [9,19,26] have not been fruitful, however, stratifying for
known T1D loci while searching for dependent effects at other
known or unknown loci may not be the best method. Studies using
simulated data have shown that the power to detect risk variants
can be increased when allowing for epistasis in addition to single
marker effects in e.g. genome-wide association studies [27]. Novel
methods taking multiple loci at a time into account may offer
possibilities of detecting interactions not detectable by classical
methods. Evaluation of suggested interactions is necessary to
support novel methods, and by no doubt replication of genetic
interactions is important, even though it is currently not obvious
how this should be done.
In the current study we have integrated several approaches and
our findings support such methods as valuable in searching for yet
unidentified genetic and functional interactions involved in the
pathogenetic processes of T1D. Evaluation of functionality is by
this approach taken into account much earlier than in classical
analyses where evaluation of functional significance is typically not
performed before the end of a study. The exact consequence of the
up- and down-regulations of the proteins in the interaction
networks, permanently or transiently, and in relation to T1D,
remains to be resolved. Our approach of measuring the
enrichment in the interaction modules of T1D associated SNPs
is a novel way of seeking also genetic support for several
interacting genes eventually combined in biological pathways.
Figure 3. Overview of predicted interactions in network D. Protein-protein interactions originates from identified genetic interactions
between a region on chromosome 17 (around D17S798, DDX52 and RPL23A) and regions on chromosome 5 (D5S429, NPM1 and RPL26L1),
chromosome 1 (D1S197, PRDX1) and chromosome 2 (D2P25, RPS7), respectively. Through the PRDX1 gene in the D1S197 region the network is linked
to the FLOT1 gene in the HLA-region. The NGB, SESN1 and SESN2 genes are positioned on chromosomes 14q24.3, 6q21 and 1p35.3, respectively. No
differential expression in lymphocytes were identified, but the NPM1 gene was significantly down-regulated and the PRDX1 gene significantly up-
regulated by cytokine-stimulation of human pancreatic islets.
doi:10.1371/journal.pone.0006250.g003
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Ethics statement
Human pancreatic islets were obtained as samples from a
multicenter European Union-supported program on beta-cell
transplantation in diabetes directed by Professor D. Pipeleers. The
program has been approved by central and local ethical
committees. Studies including human lymphocytes were approved
by the local ethics committee of Copenhagen (KA 94020gm).
Human islet preparations were obtained from nine donors (aged
8–57 years), six were male donors, three were from female donors.
Each preparation was stimulated with a mixture of cytokines
(TNF-a (5000 U/ml), IFN-c (750 U/ml) and IL-1b (75 U/ml)) for
48 hours. Lymphocyte RNA was obtained from nine controls (all
males, aged 15–35 years and without diabetes) and eight newly
diagnosed T1D patients (all males, aged 15–30 years and with
duration of T1D,20 weeks from first insulin injection and with
continued insulin treatment since). cDNA from human pancreatic
islets with and without cytokine stimulation and cDNA from
human lymphocytes from controls as well as newly diagnosed T1D
patients was used for comparing expression levels. cDNA was
prepared from total RNA by oligo-dT-primed reverse transcrip-
tion, as described by the manufacturer (TaqMan RT reagents,
Applied Biosystems, Foster City, CA, USA). Relative expression
levels of selected genes were evaluated by use of TaqMan assays.
The Low Density Array system (Applied Biosystems) containing
assays for the individual genes as well as housekeeping genes was
used on TaqMan 7900HT (Applied Biosystems). For evaluation,
expression levels of genes were normalized against the average of
three human housekeeping genes, GAPDH, 18S-RNA and PPIA,
and evaluated using the delta-delta Ct method [28]. Relative
expression levels of genes were for un-stimulated vs. cytokine
stimulated islet preparations compared by use of paired t-tests.
Expression levels between control and T1D lymphocyte cDNA
were compared by f- and t-test. P-values,0.05 were considered
statistically significant.
SNPs were mapped to genes/proteins by identifying all SNPs
categorized as tagging each gene in the Wellcome Trust Case
Control Consortium (WTCCC) genome wide association scan
data [9]. We included SNPs 5 kb upstream and 1 kb downstream
of each gene, since these regions have been shown to be strongly
enriched for gene regulatory elements important for the function
of the particular genes [29]. For each gene only the SNP with the
lowest p-value was used, to avoid introducing a bias towards genes
with many low p-value SNPs in linkage disequilibrium with each
other. For each module the significance of the enrichment of SNPs
in the best 0.1, 1 and 5 percentile was compared to 1,000
randomly generated protein interaction networks with a similar
number of proteins. The random networks were composed of
proteins of similar size as the proteins in the actual network tested
to normalize against the fact that large genes will have a higher
chance of containing T1D associated SNPs in the best percentiles
of a study due to their size alone. P-values were adjusted for
multiple testing using Bonferroni correction by multiplying the
nominal p-values with 12, which is the total amount of tests used in
this study. The significance of overlap between genes identified in
our analysis and in a paper by D’Hertog et al. [17] was calculated
using hypergeometric statistics.
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